117 related articles for article (PubMed ID: 22454485)
1. The flow-metabolic phenotype of primary colorectal cancer: assessment by integrated 18F-FDG PET/perfusion CT with histopathologic correlation.
Goh V; Engledow A; Rodriguez-Justo M; Shastry M; Peck J; Blackman G; Endozo R; Taylor S; Halligan S; Ell P; Groves AM
J Nucl Med; 2012 May; 53(5):687-92. PubMed ID: 22454485
[TBL] [Abstract][Full Text] [Related]
2. Integrated (18)F-FDG PET/CT and perfusion CT of primary colorectal cancer: effect of inter- and intraobserver agreement on metabolic-vascular parameters.
Goh V; Shastry M; Engledow A; Kozarski R; Peck J; Endozo R; Rodriguez-Justo M; Taylor SA; Halligan S; Groves AM
AJR Am J Roentgenol; 2012 Nov; 199(5):1003-9. PubMed ID: 23096172
[TBL] [Abstract][Full Text] [Related]
3. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors.
Cochet A; Pigeonnat S; Khoury B; Vrigneaud JM; Touzery C; Berriolo-Riedinger A; Dygai-Cochet I; Toubeau M; Humbert O; Coudert B; Fumoleau P; Arnould L; Brunotte F
J Nucl Med; 2012 Apr; 53(4):512-20. PubMed ID: 22343501
[TBL] [Abstract][Full Text] [Related]
5. Colorectal tumor vascularity: quantitative assessment with multidetector CT--do tumor perfusion measurements reflect angiogenesis?
Goh V; Halligan S; Daley F; Wellsted DM; Guenther T; Bartram CI
Radiology; 2008 Nov; 249(2):510-7. PubMed ID: 18812560
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT.
Sauter AW; Winterstein S; Spira D; Hetzel J; Schulze M; Mueller M; Pfannenberg C; Claussen CD; Klotz E; Hann von Weyhern C; Horger MS
J Nucl Med; 2012 Apr; 53(4):521-9. PubMed ID: 22414637
[TBL] [Abstract][Full Text] [Related]
7. Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.
Wang H; Zhang J; Tian J; Qu B; Li T; Chen Y; Liu J; Wang S
J Nucl Med; 2009 Nov; 50(11):1857-64. PubMed ID: 19837754
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of angiogenesis in colorectal carcinoma with multidetector-row CT multislice perfusion imaging.
Feng ST; Sun CH; Li ZP; Mak HK; Peng ZP; Guo HY; Meng QF
Eur J Radiol; 2010 Aug; 75(2):191-6. PubMed ID: 19481397
[TBL] [Abstract][Full Text] [Related]
9. Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET.
Cherk MH; Foo SS; Poon AM; Knight SR; Murone C; Papenfuss AT; Sachinidis JI; Saunder TH; O'Keefe GJ; Scott AM
J Nucl Med; 2006 Dec; 47(12):1921-6. PubMed ID: 17138734
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia imaging with 18F-fluoroerythronitroimidazole integrated PET/CT and immunohistochemical studies in non-small cell lung cancer.
Hu M; Xing L; Mu D; Yang W; Yang G; Kong L; Yu J
Clin Nucl Med; 2013 Aug; 38(8):591-6. PubMed ID: 23797219
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the metabolic flow phenotype of primary colorectal cancer: correlations with microvessel density are influenced by the histological scoring method.
Goh V; Rodriguez-Justo M; Engledow A; Shastry M; Endozo R; Peck J; Meagher M; Taylor SA; Halligan S; Groves AM
Eur Radiol; 2012 Aug; 22(8):1687-92. PubMed ID: 22527369
[TBL] [Abstract][Full Text] [Related]
12. Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors.
Strauss LG; Koczan D; Klippel S; Pan L; Cheng C; Willis S; Haberkorn U; Dimitrakopoulou-Strauss A
J Nucl Med; 2008 Aug; 49(8):1238-44. PubMed ID: 18632818
[TBL] [Abstract][Full Text] [Related]
13. Correlation between 18F-FDG uptake on PET and molecular biology in metastatic pulmonary tumors.
Kaira K; Okumura T; Ohde Y; Takahashi T; Murakami H; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
J Nucl Med; 2011 May; 52(5):705-11. PubMed ID: 21498541
[TBL] [Abstract][Full Text] [Related]
14. Improving Cerebral Blood Flow Through Liposomal Delivery of Angiogenic Peptides: Potential of ¹⁸F-FDG PET Imaging in Ischemic Stroke Treatment.
Hwang H; Jeong HS; Oh PS; Na KS; Kwon J; Kim J; Lim S; Sohn MH; Jeong HJ
J Nucl Med; 2015 Jul; 56(7):1106-11. PubMed ID: 25977466
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.
Manabe O; Hattori N; Hirata K; Itoh K; Hosokawa M; Takahashi H; Oyama-Manabe N; Tamaki N
J Nucl Med; 2013 May; 54(5):670-6. PubMed ID: 23516310
[TBL] [Abstract][Full Text] [Related]
16. Assessment of tumor grade and angiogenesis in colorectal cancer: whole-volume perfusion CT.
Sun H; Xu Y; Yang Q; Wang W
Acad Radiol; 2014 Jun; 21(6):750-7. PubMed ID: 24809317
[TBL] [Abstract][Full Text] [Related]
17. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.
Heusch P; Buchbender C; Köhler J; Nensa F; Gauler T; Gomez B; Reis H; Stamatis G; Kühl H; Hartung V; Heusner TA
J Nucl Med; 2014 Mar; 55(3):373-8. PubMed ID: 24504054
[TBL] [Abstract][Full Text] [Related]
18. Correlations between SUVmax and expression of GLUT1 and growth factors inducing lymphangiogenesis.
Tian M; Yu L; Zhang Y; Gao X
Acad Radiol; 2012 Apr; 19(4):420-6. PubMed ID: 22444673
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
20. Can (18)F-FDG PET/CT scan change treatment planning and be prognostic in recurrent colorectal carcinoma? A prospective and follow-up study.
Artiko V; Odalovic S; Sobic-Saranovic D; Petrovic M; Stojiljkovic M; Petrovic N; Kozarevic N; Grozdic-Milojevic I; Obradovic V
Hell J Nucl Med; 2015; 18(1):35-41. PubMed ID: 25840571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
